Structure based virtual screening: Fast and slow

[1]  G. Pazour,et al.  Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness , 2017, Scientific Reports.

[2]  David S. Goodsell,et al.  A semiempirical free energy force field with charge‐based desolvation , 2007, J. Comput. Chem..

[3]  A. Cavalli,et al.  Role of Molecular Dynamics and Related Methods in Drug Discovery. , 2016, Journal of medicinal chemistry.

[4]  F. J. Luque,et al.  Dynamic undocking and the quasi-bound state as tools for drug discovery , 2016, Nature Chemistry.

[5]  Replica-exchange molecular dynamics simulation of small peptide in water and in ethanol , 2005 .

[6]  Maria Paola Costi,et al.  Virtual Screening and X-ray Crystallography Identify Non-Substrate Analog Inhibitors of Flavin-Dependent Thymidylate Synthase. , 2016, Journal of medicinal chemistry.

[7]  Gianni De Fabritiis,et al.  KDEEP: Protein-Ligand Absolute Binding Affinity Prediction via 3D-Convolutional Neural Networks , 2018, J. Chem. Inf. Model..

[8]  Ashutosh Kumar,et al.  Advances in the Development of Shape Similarity Methods and Their Application in Drug Discovery , 2018, Front. Chem..

[9]  S. Genheden,et al.  The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities , 2015, Expert opinion on drug discovery.

[10]  Riccardo Alessandri,et al.  Protein–ligand binding with the coarse-grained Martini model , 2020, Nature Communications.

[11]  Amanda E. Wakefield,et al.  Cryptic binding sites on proteins: definition, detection, and druggability , 2018, Current Opinion in Chemical Biology.

[12]  F. Lightstone,et al.  A Comprehensive Docking and MM/GBSA Rescoring Study of Ligand Recognition upon Binding Antithrombin , 2017, Current topics in medicinal chemistry.

[13]  Robert Abel,et al.  Reaction-Based Enumeration, Active Learning, and Free Energy Calculations To Rapidly Explore Synthetically Tractable Chemical Space and Optimize Potency of Cyclin-Dependent Kinase 2 Inhibitors , 2019, J. Chem. Inf. Model..

[14]  Jacob D. Durrant,et al.  Molecular dynamics simulations and drug discovery , 2011, BMC Biology.

[15]  Holger Gohlke,et al.  Target flexibility: an emerging consideration in drug discovery and design. , 2008, Journal of medicinal chemistry.

[16]  Martin Almlöf,et al.  Free energy calculations and ligand binding. , 2003, Advances in protein chemistry.

[17]  Cristiano Ruch Werneck Guimarães,et al.  MM-GB/SA Rescoring of Docking Poses in Structure-Based Lead Optimization , 2008, J. Chem. Inf. Model..

[18]  Dmitri B. Kireev,et al.  Structural Protein–Ligand Interaction Fingerprints (SPLIF) for Structure-Based Virtual Screening: Method and Benchmark Study , 2014, J. Chem. Inf. Model..

[19]  Gianni De Fabritiis,et al.  LigVoxel: inpainting binding pockets using 3D‐convolutional neural networks , 2018, Bioinform..

[20]  Ferran Sanz,et al.  In silico models in drug development: where we are , 2018, Current opinion in pharmacology.

[21]  Maciej Majewski,et al.  Structural Stability Predicts the Binding Mode of Protein-Ligand Complexes , 2020, J. Chem. Inf. Model..

[22]  F. Noé,et al.  Protein conformational plasticity and complex ligand-binding kinetics explored by atomistic simulations and Markov models , 2015, Nature Communications.

[23]  Prasenjit Mukherjee,et al.  An overview of molecular fingerprint similarity search in virtual screening , 2016, Expert opinion on drug discovery.

[24]  Giulio Rastelli,et al.  Advances and applications of binding affinity prediction methods in drug discovery. , 2012, Biotechnology advances.

[25]  Michael M. Mysinger,et al.  Directory of Useful Decoys, Enhanced (DUD-E): Better Ligands and Decoys for Better Benchmarking , 2012, Journal of medicinal chemistry.

[26]  Irene T Weber,et al.  Design of HIV protease inhibitors targeting protein backbone: an effective strategy for combating drug resistance. , 2008, Accounts of chemical research.

[27]  Leslie A Kuhn,et al.  Side‐chain flexibility in protein–ligand binding: The minimal rotation hypothesis , 2005, Protein science : a publication of the Protein Society.

[28]  Kevan M. Shokat,et al.  K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions , 2013, Nature.

[29]  Gianni De Fabritiis,et al.  DeltaDelta neural networks for lead optimization of small molecule potency† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c9sc04606b , 2019, Chemical science.

[30]  Minoru Yoshida,et al.  Identification of Sumoylation Activating Enzyme 1 Inhibitors by Structure-Based Virtual Screening , 2013, J. Chem. Inf. Model..

[31]  Peter Kolb,et al.  Docking screens: right for the right reasons? , 2009, Current topics in medicinal chemistry.

[32]  Sheng-You Huang,et al.  Comprehensive assessment of flexible‐ligand docking algorithms: current effectiveness and challenges , 2018, Briefings Bioinform..

[33]  Patrick B. Grinaway,et al.  Towards chemical accuracy for alchemical free energy calculations with hybrid physics-based machine learning / molecular mechanics potentials , 2020, bioRxiv.

[34]  Z. Deng,et al.  Structural interaction fingerprint (SIFt): a novel method for analyzing three-dimensional protein-ligand binding interactions. , 2004, Journal of medicinal chemistry.

[35]  Jian-Xin Zhu,et al.  Topological-insulator-based terahertz modulator , 2017, Scientific Reports.

[36]  Jian Wang,et al.  MedusaDock 2.0: Efficient and Accurate Protein-Ligand Docking With Constraints , 2019, J. Chem. Inf. Model..

[37]  Albert C. Pan,et al.  Transitions to catalytically inactive conformations in EGFR kinase , 2013, Proceedings of the National Academy of Sciences.

[38]  Bryce K. Allen,et al.  Relative Binding Free Energy Calculations in Drug Discovery: Recent Advances and Practical Considerations , 2017, J. Chem. Inf. Model..

[39]  Ricardo L. Mancera,et al.  Ligand-Protein Docking with Water Molecules , 2008, J. Chem. Inf. Model..

[40]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[41]  Albert C. Pan,et al.  Pathway and mechanism of drug binding to G-protein-coupled receptors , 2011, Proceedings of the National Academy of Sciences.

[42]  B. Shoichet,et al.  Molecular docking and ligand specificity in fragment-based inhibitor discovery. , 2009, Nature chemical biology.

[43]  Yurii S. Moroz,et al.  Ultra-large library docking for discovering new chemotypes , 2019, Nature.

[44]  A. Caflisch,et al.  High-Throughput Fragment Docking into the BAZ2B Bromodomain: Efficient in Silico Screening for X-Ray Crystallography. , 2016, ACS chemical biology.

[45]  G Klebe,et al.  Energetic and entropic factors determining binding affinity in protein-ligand complexes. , 1997, Journal of receptor and signal transduction research.

[46]  Carl Petersson,et al.  In Silico Absorption, Distribution, Metabolism, Excretion, and Pharmacokinetics (ADME-PK): Utility and Best Practices. An Industry Perspective from the International Consortium for Innovation through Quality in Pharmaceutical Development. , 2017, Journal of medicinal chemistry.

[47]  Gianni De Fabritiis,et al.  PlayMolecule CrypticScout: Predicting Protein Cryptic Sites Using Mixed-Solvent Molecular Simulations , 2020, J. Chem. Inf. Model..

[48]  Y. Zou,et al.  Dopamine D3 receptor antagonist reveals a cryptic pocket in aminergic GPCRs , 2018, Scientific Reports.

[49]  Christopher L. McClendon,et al.  Reaching for high-hanging fruit in drug discovery at protein–protein interfaces , 2007, Nature.

[50]  Gianni De Fabritiis,et al.  Molecular-Simulation-Driven Fragment Screening for the Discovery of New CXCL12 Inhibitors , 2018, J. Chem. Inf. Model..

[51]  B. Honig,et al.  A hierarchical approach to all‐atom protein loop prediction , 2004, Proteins.

[52]  Silvia Conti,et al.  Low-voltage 2D materials-based printed field-effect transistors for integrated digital and analog electronics on paper , 2019, Nature Communications.

[53]  Friedrich Rippmann,et al.  Large-Scale Assessment of Binding Free Energy Calculations in Active Drug Discovery Projects , 2020, J. Chem. Inf. Model..

[54]  M J Harvey,et al.  ACEMD: Accelerating Biomolecular Dynamics in the Microsecond Time Scale. , 2009, Journal of chemical theory and computation.

[55]  C. E. Peishoff,et al.  A critical assessment of docking programs and scoring functions. , 2006, Journal of medicinal chemistry.

[56]  Matthew P. Repasky,et al.  Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. , 2004, Journal of medicinal chemistry.

[57]  Z. Xiang,et al.  On the role of the crystal environment in determining protein side-chain conformations. , 2002, Journal of molecular biology.

[58]  Xavier Barril,et al.  rDock: A Fast, Versatile and Open Source Program for Docking Ligands to Proteins and Nucleic Acids , 2014, PLoS Comput. Biol..

[59]  M. Gilson,et al.  Ligand configurational entropy and protein binding , 2007, Proceedings of the National Academy of Sciences.

[60]  Artem Cherkasov,et al.  Deep Docking: A Deep Learning Platform for Augmentation of Structure Based Drug Discovery , 2020, ACS central science.

[61]  Oliver Koch,et al.  A novel interaction fingerprint derived from per atom score contributions: exhaustive evaluation of interaction fingerprint performance in docking based virtual screening , 2018, Journal of Cheminformatics.

[62]  Maciej Majewski,et al.  SkeleDock: A Web Application for Scaffold Docking in PlayMolecule , 2020, J. Chem. Inf. Model..

[63]  Victor Guallar,et al.  Adaptive simulations, towards interactive protein-ligand modeling , 2017, Scientific Reports.

[64]  J. S. Dixon,et al.  Evaluation of the CASP2 docking section , 1997, Proteins.

[65]  Julien Michel,et al.  Prediction of the water content in protein binding sites. , 2009, The journal of physical chemistry. B.

[66]  Markus A. Lill,et al.  Exploring the Potential of Protein-Based Pharmacophore Models in Ligand Pose Prediction and Ranking , 2013, J. Chem. Inf. Model..

[67]  Johannes C. Hermann,et al.  Structure-based activity prediction for an enzyme of unknown function , 2007, Nature.

[68]  D Horvath,et al.  A virtual screening approach applied to the search for trypanothione reductase inhibitors. , 1997, Journal of medicinal chemistry.

[69]  Maria Paola Costi,et al.  Comprehensive mechanistic analysis of hits from high-throughput and docking screens against beta-lactamase. , 2008, Journal of medicinal chemistry.

[70]  Maxwell I. Zimmerman,et al.  Designing small molecules to target cryptic pockets yields both positive and negative allosteric modulators , 2017, PloS one.

[71]  M. Parrinello,et al.  Funnel metadynamics as accurate binding free-energy method , 2013, Proceedings of the National Academy of Sciences.

[72]  Roland L. Dunbrack,et al.  Conformational Analysis of the DFG-Out Kinase Motif and Biochemical Profiling of Structurally Validated Type II Inhibitors , 2014, Journal of medicinal chemistry.

[73]  P. Kollman,et al.  Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. , 2000, Accounts of chemical research.

[74]  Gisbert Schneider,et al.  Drug discovery with explainable artificial intelligence , 2020, Nature Machine Intelligence.

[75]  Huanwang Yang,et al.  D3R grand challenge 4: blind prediction of protein–ligand poses, affinity rankings, and relative binding free energies , 2020, Journal of Computer-Aided Molecular Design.

[76]  Zhihai Liu,et al.  Comparative Assessment of Scoring Functions on an Updated Benchmark: 2. Evaluation Methods and General Results , 2014, J. Chem. Inf. Model..

[77]  Claudio N. Cavasotto,et al.  Exponential consensus ranking improves the outcome in docking and receptor ensemble docking , 2019, Scientific Reports.

[78]  V. Berdini,et al.  Crystal structure of calf spleen purine nucleoside phosphorylase complexed to a novel purine analogue , 2007, FEBS letters.

[79]  M Hendlich,et al.  LIGSITE: automatic and efficient detection of potential small molecule-binding sites in proteins. , 1997, Journal of molecular graphics & modelling.

[80]  G. Tresadern,et al.  Multibody cofactor and substrate molecular recognition in the myo-inositol monophosphatase enzyme , 2016, Scientific Reports.

[81]  David Ryan Koes,et al.  Visualizing Convolutional Neural Network Protein-Ligand Scoring , 2018, Journal of molecular graphics & modelling.

[82]  Heather A Carlson,et al.  Moving Beyond Active-Site Detection: MixMD Applied to Allosteric Systems. , 2016, The journal of physical chemistry. B.

[83]  T. Clackson,et al.  Structural Analysis of DFG‐in and DFG‐out Dual Src‐Abl Inhibitors Sharing a Common Vinyl Purine Template , 2009, Chemical biology & drug design.

[84]  Kam Y. J. Zhang,et al.  Hierarchical virtual screening approaches in small molecule drug discovery , 2014, Methods.

[85]  F. J. Luque,et al.  Binding site detection and druggability index from first principles. , 2009, Journal of medicinal chemistry.

[86]  Norman Tran,et al.  Molecular Recognition: Lock-and-Key, Induced Fit, and Conformational Selection , 2020, Encyclopedia of Biophysics.

[87]  A. Cavalli,et al.  Dynamic Docking: A Paradigm Shift in Computational Drug Discovery , 2017, Molecules.

[88]  Joel S. Freundlich,et al.  Identification of a Novel Drug Lead That Inhibits HCV Infection and Cell-to-Cell Transmission by Targeting the HCV E2 Glycoprotein , 2014, PloS one.

[89]  H. Clark,et al.  Corrigendum: The extracellular interactome of the human adenovirus family reveals diverse strategies for immunomodulation , 2017, Nature Communications.

[90]  Shuai Liu,et al.  Continuous Evaluation of Ligand Protein Predictions: A Weekly Community Challenge for Drug Docking. , 2019, Structure.

[91]  Jianyou Shi,et al.  Assessing the performance of docking scoring function, FEP, MM-GBSA, and QM/MM-GBSA approaches on a series of PLK1 inhibitors. , 2017, MedChemComm.

[92]  E. Jaeger,et al.  Docking: successes and challenges. , 2005, Current pharmaceutical design.

[93]  S. Doerr,et al.  On-the-Fly Learning and Sampling of Ligand Binding by High-Throughput Molecular Simulations. , 2014, Journal of chemical theory and computation.

[94]  Richard D. Taylor,et al.  Improved protein–ligand docking using GOLD , 2003, Proteins.

[95]  Tian Zhu,et al.  Hit identification and optimization in virtual screening: practical recommendations based on a critical literature analysis. , 2013, Journal of medicinal chemistry.

[96]  Tingjun Hou,et al.  Assessing the performance of the molecular mechanics/Poisson Boltzmann surface area and molecular mechanics/generalized Born surface area methods. II. The accuracy of ranking poses generated from docking , 2011, J. Comput. Chem..

[97]  M. Murcko,et al.  Consensus scoring: A method for obtaining improved hit rates from docking databases of three-dimensional structures into proteins. , 1999, Journal of medicinal chemistry.

[98]  Roderick E. Hubbard,et al.  Current perspectives in fragment-based lead discovery (FBLD) , 2017, Essays in biochemistry.

[99]  William L Jorgensen,et al.  Perspective on Free-Energy Perturbation Calculations for Chemical Equilibria. , 2008, Journal of chemical theory and computation.

[100]  B. Shoichet,et al.  Soft docking and multiple receptor conformations in virtual screening. , 2004, Journal of medicinal chemistry.

[101]  Somesh D. Sharma,et al.  Managing protein flexibility in docking and its applications. , 2009, Drug discovery today.

[102]  M. Lill,et al.  Decision Making in Structure-Based Drug Discovery: Visual Inspection of Docking Results. , 2021, Journal of medicinal chemistry.

[103]  Gianni De Fabritiis,et al.  From Target to Drug: Generative Modeling for Multimodal Structure-Based Ligand Design. , 2019, Molecular pharmaceutics.

[104]  Arthur J. Olson,et al.  AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..

[105]  Victor Guallar,et al.  PELE:  Protein Energy Landscape Exploration. A Novel Monte Carlo Based Technique. , 2005, Journal of chemical theory and computation.

[106]  Jonathan C. Fuller,et al.  Protein Binding Pocket Dynamics. , 2016, Accounts of chemical research.

[107]  Marc C. Nicklaus,et al.  Combining docking with pharmacophore filtering for improved virtual screening , 2009, J. Cheminformatics.

[108]  David H. Freedman,et al.  Hunting for New Drugs with AI , 2019, Nature.

[109]  A. Poso,et al.  Binding Affinity via Docking: Fact and Fiction , 2018, Molecules.

[110]  R. Friesner,et al.  Novel procedure for modeling ligand/receptor induced fit effects. , 2006, Journal of medicinal chemistry.

[111]  Richard J. Hall,et al.  Protein-Ligand Docking against Non-Native Protein Conformers , 2008, J. Chem. Inf. Model..

[112]  David Ryan Koes,et al.  Protein-Ligand Scoring with Convolutional Neural Networks , 2016, Journal of chemical information and modeling.

[113]  Eric T. Kim,et al.  How does a drug molecule find its target binding site? , 2011, Journal of the American Chemical Society.

[114]  Arthur J. Olson,et al.  A Virtual Screen Discovers Novel, Fragment-Sized Inhibitors of Mycobacterium tuberculosis InhA , 2015, J. Chem. Inf. Model..

[115]  David S. Goodsell,et al.  Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function , 1998 .

[116]  I. Peretz,et al.  Individual Differences in Rhythmic Cortical Entrainment Correlate with Predictive Behavior in Sensorimotor Synchronization , 2016, Scientific Reports.

[117]  Ajay N. Jain,et al.  Knowledge-guided docking: accurate prospective prediction of bound configurations of novel ligands using Surflex-Dock , 2015, Journal of Computer-Aided Molecular Design.

[118]  Herman van Vlijmen,et al.  Collaborating to improve the use of free-energy and other quantitative methods in drug discovery , 2016, Journal of Computer-Aided Molecular Design.

[119]  Vijay S. Pande,et al.  Everything you wanted to know about Markov State Models but were afraid to ask. , 2010, Methods.

[120]  Ferran Sanz,et al.  Membrane cholesterol access into a G-protein-coupled receptor , 2017, Nature Communications.

[121]  A. Laio,et al.  Flexible docking in solution using metadynamics. , 2005, Journal of the American Chemical Society.

[122]  G. Bowman,et al.  Equilibrium fluctuations of a single folded protein reveal a multitude of potential cryptic allosteric sites , 2012, Proceedings of the National Academy of Sciences.

[123]  Benjamin P. Cossins,et al.  Understanding Cryptic Pocket Formation in Protein Targets by Enhanced Sampling Simulations. , 2016, Journal of the American Chemical Society.

[124]  Gregory R. Bowman,et al.  A cryptic pocket in Ebola VP35 allosterically controls RNA binding , 2020, Nature Communications.

[125]  Pratyush Tiwary,et al.  Prediction of Protein-Ligand Binding Poses via a Combination of Induced Fit Docking and Metadynamics Simulations. , 2016, Journal of chemical theory and computation.

[126]  S. Henikoff,et al.  Corrigendum: ChEC-seq kinetics discriminates transcription factor binding sites by DNA sequence and shape in vivo , 2015, Nature Communications.

[127]  T. Ferrand,et al.  Physical mechanisms of oceanic mantle earthquakes: Comparison of natural and experimental events , 2018, Scientific Reports.

[128]  Talambedu Usha,et al.  Recent Updates on Computer-aided Drug Discovery: Time for a Paradigm Shift. , 2017, Current topics in medicinal chemistry.

[129]  Andrea Spitaleri,et al.  Fast Dynamic Docking Guided by Adaptive Electrostatic Bias: The MD-Binding Approach. , 2018, Journal of chemical theory and computation.

[130]  S. Balaz,et al.  A practical approach to docking of zinc metalloproteinase inhibitors. , 2004, Journal of molecular graphics & modelling.

[131]  Stephani Joy Y Macalino,et al.  Role of computer-aided drug design in modern drug discovery , 2015, Archives of Pharmacal Research.

[132]  G. de Fabritiis,et al.  Complete reconstruction of an enzyme-inhibitor binding process by molecular dynamics simulations , 2011, Proceedings of the National Academy of Sciences.

[133]  Todd J. A. Ewing,et al.  DOCK 4.0: Search strategies for automated molecular docking of flexible molecule databases , 2001, J. Comput. Aided Mol. Des..

[134]  Jordi Mestres,et al.  Guided docking approaches to structure-based design and screening. , 2004, Current topics in medicinal chemistry.

[135]  Rommie E. Amaro,et al.  Ensemble Docking in Drug Discovery. , 2018, Biophysical journal.

[136]  Kathryn M Hart,et al.  Discovery of multiple hidden allosteric sites by combining Markov state models and experiments , 2015, Proceedings of the National Academy of Sciences.

[137]  Giulio Rastelli,et al.  Structure-based design of potent aromatase inhibitors by high-throughput docking. , 2011, Journal of medicinal chemistry.

[138]  John B. O. Mitchell,et al.  A machine learning approach to predicting protein-ligand binding affinity with applications to molecular docking , 2010, Bioinform..

[139]  S. Kelm,et al.  Reconstruction of apo A2A receptor activation pathways reveal ligand-competent intermediates and state-dependent cholesterol hotspots , 2019, Scientific Reports.